Trial therapy with proton-pump inhibitors is not a suitable test for gastro-oesophageal reflux disease; a meta-analysis of the diagnostic-test characteristics;Proejbehandeling met protonpompremmers ongeschikt als test voor gastro-oesofageale refluxziekte; een meta-analyse van de diagnostische- testeigenschappen

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 39, 2004, Pages 1924-1928

  Numans, M E ^a,b   Lau, J ^b   De Wit, N J ^a   Bonis, P A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; PROTON PUMP;

CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMAN; META ANALYSIS; MULTICENTER STUDY; QUESTIONNAIRE; REVIEW; ROC CURVE; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; DOSE RESPONSE; DRUG ANTAGONISM; PH; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; TIME;

DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS; HYDROGEN-ION CONCENTRATION; PREDICTIVE VALUE OF TESTS; PROTON PUMPS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 4644282748     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop report. Genval Workshop Group. Gut 1999;44(Suppl 2):S1-16.
2. Numans ME, Wit NJ de, Dirven JAM, Hurenkamp GJB, Meijer QCM, Muris JWM, et al. NHG-standaard Maagklachten (tweede herziening). Huisarts Wet 2003;46:690-700.
3. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997;92:1997-2000.
4. Juul-Hansen P, Rydning A, Jacobsen CD, Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001;36:806-10.
5. Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999;159:2161-8.
6. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:59-66.
7. Deville WL, Bezemer PD, Bouter LM. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol 2000;53:65-9.
8. Mulrow D, Linn WD, Gaul MK, Pugh JA. Assessing quality of a diagnostic test evaluation. J Gen Intern Med 1989;4:288-95.
9. Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000;14:389-96.
10. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-316.
11. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998;10:119-24.
12. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765-73.
13. Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P, et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999;319:550-3.
14. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998;33:15-20.
15. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997;32:965-73.
16. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993;13:313-21.
17. Lau J. Meta-test version 0.6. Boston: New England Medical Center; 1997.
18. Johnsson F, Hatlebakk JG, Klintenberg AC, Roman J, Toth E, Stubberod A. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003;38:354-9.
19. Brun J, Sorngard H. High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care. Fam Pract 2000;17:401-4.
20. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-65.
21. Lewin van den Broek NT, Numans ME, Buskens E, Verheij TJ, Wit NJ de, Smout AJ. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract 2001;51:619-24.
22. Dupas JL, Houcke P, Samoyeau R. Pantoprazole versus lansoprazole in French patients with reflux esophagitis. French Collaborative Pantaprazole Study Group. Gastroenterol Clin Biol 2001;25:245-50.
23. Farup PG, Hovde O, Torp R, Wetterhus S. Patients with functional dyspepsia responding to omeprazole have a characteristic gastrooesophageal reflux pattern. Scand J Gastroenterol 1999;34:575-9.
24. Pinxteren B, Numans ME, Lau J, Wit NJ de, Hungin AP, Bonis PA. Short-term treatment of gastroesophageal reflux disease. J Gen Int Med 2003;18:755-63.